Jirun Peng

5.6k total citations · 3 hit papers
26 papers, 2.5k citations indexed

About

Jirun Peng is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jirun Peng has authored 26 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Immunology. Recurrent topics in Jirun Peng's work include Cancer Immunotherapy and Biomarkers (6 papers), Epigenetics and DNA Methylation (5 papers) and Immune Cell Function and Interaction (5 papers). Jirun Peng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Epigenetics and DNA Methylation (5 papers) and Immune Cell Function and Interaction (5 papers). Jirun Peng collaborates with scholars based in China and United States. Jirun Peng's co-authors include Zemin Zhang, Qiming Zhang, Xueda Hu, Huahu Guo, Boxi Kang, Yuanyuan Zhang, Xinyi Guo, Ming-Hui Dong, Zhouzerui Liu and Chunhong Zheng and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and Cancer Cell.

In The Last Decade

Jirun Peng

26 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing

2017 1.4k citations Huahu Guo, Boxi Kang et al. Cell profile →
Immune phenotypic linkage between colorectal cancer and liver metastasis

2022 263 citations Yedan Liu, Qiming Zhang et al. Cancer Cell profile →
A pan-cancer single-cell panorama of human natural killer cells

2023 187 citations Fei Tang, Jinhu Li et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jirun Peng China	16	1.2k	1.1k	1.1k	624	363	26	2.5k
Wei Yuan China	32	1.2k 1.0×	912 0.8×	882 0.8×	558 0.9×	399 1.1×	106	2.9k
Su Yin Lim Australia	28	1.3k 1.1×	1.4k 1.2×	1.6k 1.4×	474 0.8×	415 1.1×	50	3.1k
Khalid Al‐Shibli Norway	28	1.3k 1.1×	916 0.8×	1.8k 1.5×	979 1.6×	810 2.2×	44	3.2k
Antonella Argentiero Italy	23	596 0.5×	406 0.4×	794 0.7×	427 0.7×	326 0.9×	48	1.6k
Sean P. Pitroda United States	33	1.1k 0.9×	933 0.8×	1.8k 1.5×	677 1.1×	1.0k 2.8×	94	3.4k
Won Jin Ho United States	18	612 0.5×	629 0.5×	1.3k 1.2×	438 0.7×	340 0.9×	59	2.1k
Ming Lü China	20	812 0.7×	622 0.5×	449 0.4×	553 0.9×	228 0.6×	40	1.7k
Li Zhou China	32	1.5k 1.3×	314 0.3×	905 0.8×	1.0k 1.7×	297 0.8×	118	2.7k
Zachary Boyd United States	14	1.1k 0.9×	1.2k 1.0×	2.3k 2.1×	731 1.2×	650 1.8×	27	3.7k
Joe Stephenson United States	25	894 0.8×	429 0.4×	1.1k 1.0×	360 0.6×	488 1.3×	65	2.0k

Countries citing papers authored by Jirun Peng

Since Specialization

Citations

This map shows the geographic impact of Jirun Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jirun Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jirun Peng more than expected).

Fields of papers citing papers by Jirun Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jirun Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jirun Peng. The network helps show where Jirun Peng may publish in the future.

Co-authorship network of co-authors of Jirun Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jirun Peng. A scholar is included among the top collaborators of Jirun Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jirun Peng. Jirun Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luo, Nan, Mengmeng Xiao, Feng Feng, et al.. (2025). Circulating cell-free DNA methylation analysis of pancreatic cancer patients for early noninvasive diagnosis. Frontiers in Oncology. 15. 1552426–1552426. 1 indexed citations

Liu, Dongfang, Chen Li, Nan Luo, et al.. (2024). Multi-omics analysis reveals the landscape of tumor microenvironments in left-sided and right-sided colon cancer. Frontiers in Medicine. 11. 1403171–1403171. 4 indexed citations

Tang, Fei, Jinhu Li, Lu Qi, et al.. (2023). A pan-cancer single-cell panorama of human natural killer cells. Cell. 186(19). 4235–4251.e20. 187 indexed citations breakdown →

Ren, Mingxing, Yunfei Miao, Shi Chen, et al.. (2022). Dual selective sensor for exosomes in serum using magnetic imprinted polymer isolation sandwiched with aptamer/graphene oxide based FRET fluorescent ignition. Biosensors and Bioelectronics. 207. 114112–114112. 53 indexed citations

Liu, Yedan, Qiming Zhang, Baocai Xing, et al.. (2022). Immune phenotypic linkage between colorectal cancer and liver metastasis. Cancer Cell. 40(4). 424–437.e5. 263 indexed citations breakdown →

Liu, Dongfang, Nan Luo, Tingting Liu, et al.. (2021). Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 8. 1607–1622. 8 indexed citations

Xiao, Mengmeng, Dexiao Du, Nan Luo, et al.. (2021). DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer. OncoTargets and Therapy. Volume 14. 2003–2017. 26 indexed citations

Liu, Xiaomeng, Jie Ren, Nan Luo, et al.. (2019). Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq). Clinical Epigenetics. 11(1). 93–93. 52 indexed citations

Yang, Rui, Sijin Cheng, Nan Luo, et al.. (2019). Distinct epigenetic features of tumor-reactive CD8+ T cells in colorectal cancer patients revealed by genome-wide DNA methylation analysis. Genome biology. 21(1). 2–2. 97 indexed citations

10.

Sun, Bowen, et al.. (2018). Programmed Death Receptor 1 (PD1) Knockout and Human Telomerase Reverse Transcriptase (hTERT) Transduction Can Enhance Persistence and Antitumor Efficacy of Cytokine-Induced Killer Cells Against Hepatocellular Carcinoma. Medical Science Monitor. 24. 4573–4582. 9 indexed citations

11.

Liu, Ningning, Jinfang Zhang, Xiaohai Yang, et al.. (2017). HDM2 Promotes NEDDylation of Hepatitis B Virus HBx To Enhance Its Stability and Function. Journal of Virology. 91(16). 47 indexed citations

12.

Rong, Lijie, Yangyang Bian, Shubai Liu, et al.. (2017). Identifying tumor promoting genomic alterations in tumor-associated fibroblasts via retrovirus-insertional mutagenesis. Oncotarget. 8(57). 97231–97245. 5 indexed citations

13.

Guo, Limin, et al.. (2017). Detection of circulating tumor cells by reverse transcription-quantitative polymerase chain reaction and magnetic activated cell sorting in the peripheral blood of patients with hepatocellular carcinoma. Molecular Medicine Reports. 16(5). 5894–5900. 11 indexed citations

14.

Wen, Lu, Jingyi Li, Huahu Guo, et al.. (2015). Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients. Cell Research. 25(11). 1250–1264. 105 indexed citations

15.

Gong, Lei, et al.. (2014). 3-Bromopyruvic Acid, A Hexokinase II Inhibitor, is an Effective Antitumor Agent on the Hepatoma Cells : in vitro and in vivo Findings. Anti-Cancer Agents in Medicinal Chemistry. 14(5). 771–776. 39 indexed citations

16.

Liu, Ningning, Jinfang Zhang, Tong Jiao, et al.. (2013). Hepatitis B Virus Inhibits Apoptosis of Hepatoma Cells by Sponging the MicroRNA 15a/16 Cluster. Journal of Virology. 87(24). 13370–13378. 45 indexed citations

17.

Chen, Pengcheng, Jirun Peng, Wenzhen Wang, et al.. (2013). Overexpression of human telomerase reverse transcriptase promotes the motility and invasiveness of HepG2 cells in vitro. Oncology Reports. 30(3). 1157–1164. 17 indexed citations

18.

Gong, Lei, Hui Han, Limin Guo, et al.. (2011). Simultaneous Measurements of Serum AFP, GPC-3 and HCCR for Diagnosing Hepatocellular Carcinoma. Hepatogastroenterology. 58(110-111). 1718–24. 51 indexed citations

19.

Chen, Lei, Sarwat Fatima, Jirun Peng, & Xi-sheng Leng. (2009). SELDI Protein Chip Technology for the Detection of Serum Biomarkers for Liver Disease. Protein and Peptide Letters. 16(5). 467–472. 14 indexed citations

20.

Li, Tao, et al.. (2006). Effects of 5-hydroxytamine and its antagonists on hepatic stellate cells.. PubMed. 5(1). 96–100. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact